Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a Section 232 investigation Read more
Syngene collaborates with biotech firm to develop bile acid modulator for cholestatic disease treatment Read more
The pharmaceutical retail industry: a paradigm shift for growth and compliance driven by data visibility Read more